FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/08/015275 [Registered on: 10/08/2018] Trial Registered Prospectively
Last Modified On: 12/08/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Other (Specify) [Supplementation]  
Study Design  Non-randomized, Placebo Controlled Trial 
Public Title of Study   Effect of Vitamin E in treatment resistant Epilepsy 
Scientific Title of Study   Role of vitamin E supplementation in treatment resistant epilepsy in children in the age group 1-12 years 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Muhammed Shabeer P 
Designation  Junior resident  
Affiliation  GMCH Aurangabad 
Address  Department of paediatrics GMCH Aurangabad
GMCH Aurangabad
Aurangabad
MAHARASHTRA
431001
India 
Phone  9562028461  
Fax    
Email  mohdshabeerp@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr PS Patil 
Designation  Head and professor, department of paediatrics 
Affiliation  GMCH Aurangabad 
Address  Department of paediatrics GMCH Aurangabad
GMCH Aurangabad Maharashtra
Aurangabad
MAHARASHTRA
431001
India 
Phone    
Fax    
Email  dr_prashantpatil@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr PS Patil 
Designation  Head and professor, department of paediatrics 
Affiliation  GMCH Aurangabad 
Address  Department of paediatrics GMCH Aurangabad
GMCH Aurangabad Maharashtra
Aurangabad
MAHARASHTRA
431001
India 
Phone    
Fax    
Email  dr_prashantpatil@yahoo.com  
 
Source of Monetary or Material Support  
Epilepsy clinic and ward 24 and 25 GMCH Aurangabad, Paediatric OPD GMCH Aurangabad 
 
Primary Sponsor  
Name  Muhammed Shabeer P 
Address  Junior resident Department of Paediatrics GMCH Aurangabad  
Type of Sponsor  Other [Principal investigator] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Muhammed Shabeer P  GMCH Aurangabad  GMCH Aurangabad Padiatric Ward 24 and 25, Epilepsy Clinic , Paediatric OPD
Aurangabad
MAHARASHTRA 
9562028461

mohdshabeerp@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  Epilepsy, (1) ICD-10 Condition: G40||Epilepsy and recurrent seizures, (2) ICD-10 Condition: G404||Other generalized epilepsy and epileptic syndromes,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Placebo  Other group revive antiepileptic agents 
Intervention  Vitamin E  Vitamin E supplemented with anticonvulsant , antiepilectics which is needed for the child. Vitamin E according upper limit of RDA, for 6 months. 
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Age 1-12 years
Diagnosis of treatment resistant epilepsy
A) Recieving any of at least two anti convulsant drugs for past 6 months
B) at least 3 seizures in last 6 months
C) the ability of family or friends to count the number of seizures in epileptic patients during the determined period 
 
ExclusionCriteria 
Details  Neuroimaging suggestive of mass lesion
Receiving vitamin E supplementation within 6 months of study
Presence of live and kidney disease  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study effect of Vitamin E supplementation in the reduction of seizure episodes in treatment resistant epilepsy patients on antiepileptuc drugs  6 months 
 
Secondary Outcome  
Outcome  TimePoints 
To study seizure episode reduction in different types of seizure in Vitamin E supplemented children
To study correlation of vitamin E supplementation and reduction of seizure episodes with different antiepileptic drugs
To study side effects of vitamin E in supplemented group 
6 months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "32"
Final Enrollment numbers achieved (India)="32" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/08/2018 
Date of Study Completion (India) 30/11/2019 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Not yet published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Vitamin E is a antioxidant , oxidative stress is important pathogen for epilepsy and many of anti epileptic drugs produces oxidative stress, so vitamin E can act here.
Here Vitamin E is supplementing to treatment resistant epilepsy in addition to anticoagulant drugs for 6 months , study the outcomes like reduction in seizure episodes, relation with antiepileptic drugs and also side effects of vitamin E if any. EEG will be recorded before and after study.
Study completed,  concluded that Vitamin helpful in reducing the number seizure lasting more than 5 min ( impending status).
No significant change in number seizure , EEG changes , antiepileptic drugs after supplementing vitamin E to children with treatment resistant epilepsy 
 
Close